Literature DB >> 21242514

A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.

Yoshiko Fukuyama1, Janice D King, Kosuke Kataoka, Ryoki Kobayashi, Rebekah S Gilbert, Susan K Hollingshead, David E Briles, Kohtaro Fujihashi.   

Abstract

Our previous study showed that a combination of a plasmid-expressing Flt3 ligand (pFL) and CpG oligodeoxynucleotides (CpG ODN) as a combined nasal adjuvant elicited mucosal immune responses in aged (2-y-old) mice. In this study, we investigated whether a combination of pFL and CpG ODN as a nasal adjuvant for a pneumococcal surface protein A (PspA) would enhance PspA-specific secretory-IgA Ab responses, which could provide protective mucosal immunity against Streptococcus pneumoniae infection in aged mice. Nasal immunization with PspA plus a combination of pFL and CpG ODN elicited elevated levels of PspA-specific secretory-IgA Ab responses in external secretions and plasma in both young adult and aged mice. Significant levels of PspA-specific CD4(+) T cell proliferative and PspA-induced Th1- and Th2- type cytokine responses were noted in nasopharyngeal-associated lymphoreticular tissue, cervical lymph nodes, and spleen of aged mice, which were equivalent to those in young adult mice. Additionally, increased numbers of mature-type CD8, CD11b-expressing dendritic cells were detected in mucosal inductive and effector lymphoid tissues of aged mice. Importantly, aged mice given PspA plus a combination of pFL and CpG ODN showed protective immunity against nasal S. pneumoniae colonization. These results demonstrate that nasal delivery of a combined DNA adjuvant offers an attractive possibility for protection against S. pneumoniae in the elderly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242514     DOI: 10.4049/jimmunol.1002837

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells.

Authors:  Akitoshi Tsuruhara; Kazuyoshi Aso; Daisuke Tokuhara; Junichiro Ohori; Masaki Kawabata; Yuichi Kurono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Int Immunol       Date:  2017-01-01       Impact factor: 4.823

Review 2.  Novel vaccine development strategies for inducing mucosal immunity.

Authors:  Yoshiko Fujkuyama; Daisuke Tokuhara; Kosuke Kataoka; Rebekah S Gilbert; Jerry R McGhee; Yoshikazu Yuki; Hiroshi Kiyono; Kohtaro Fujihashi
Journal:  Expert Rev Vaccines       Date:  2012-03       Impact factor: 5.217

Review 3.  Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly.

Authors:  Kohtaro Fujihashi; Shintaro Sato; Hiroshi Kiyono
Journal:  Exp Gerontol       Date:  2014-01-16       Impact factor: 4.032

4.  Murine germinal center B cells require functional Fms-like tyrosine kinase 3 signaling for IgG1 class-switch recombination.

Authors:  Mattias N D Svensson; Karin M E Andersson; Caroline Wasén; Malin C Erlandsson; Merja Nurkkala-Karlsson; Ing-Marie Jonsson; Mikael Brisslert; Mats Bemark; Maria I Bokarewa
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

Review 5.  Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-Review.

Authors:  Shintaro Sato; Hiroshi Kiyono; Kohtaro Fujihashi
Journal:  Gerontology       Date:  2014-12-20       Impact factor: 5.140

Review 6.  Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.

Authors:  Kosuke Kataoka; Yoshiko Fukuyama; David E Briles; Tatsuro Miyake; Kohtaro Fujihashi
Journal:  Microbiol Immunol       Date:  2017-06       Impact factor: 1.955

7.  Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model.

Authors:  Qing Pan; Roshan Pais; Adaugo Ohandjo; Cheng He; Qing He; Yusuf Omosun; J U Igietseme; F O Eko
Journal:  Vaccine       Date:  2015-02-17       Impact factor: 3.641

8.  Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults.

Authors:  Karen M Haas; Maria W Blevins; Kevin P High; Bing Pang; W Edward Swords; Rama D Yammani
Journal:  J Infect Dis       Date:  2013-08-20       Impact factor: 5.226

Review 9.  Pneumococcal Capsular Polysaccharide Immunity in the Elderly.

Authors:  Hugh Adler; Daniela M Ferreira; Stephen B Gordon; Jamie Rylance
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

10.  Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine.

Authors:  Shakyra Richardson; Fnu Medhavi; Tayhlor Tanner; Stephanie Lundy; Yusuf Omosun; Joseph U Igietseme; Darin Carroll; Francis O Eko
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.